The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficient. [electronic resource]
Producer: 20120112Description: 1959-60; author reply 1961 p. digitalISSN:- 1473-4877
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.